House Bill
|
1074
|
An Act relative to cancer patient access to biomarker testing to provide appropriate therapy
|
Support
|
$0.00
|
N/A
|
House Bill
|
978
|
An Act relative to promoting healthcare access and affordability for patients
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
609
|
An Act relative to consumer deductibles
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
612
|
An Act relative to promoting healthcare access and affordability for patients
|
Support
|
$0.00
|
N/A
|
House Bill
|
945
|
An Act to ensure prescription drug cost transparency and affordability
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
689
|
An Act relative to patient access to biomarker testing to provide appropriate therapy
|
Support
|
$0.00
|
N/A
|
House Bill
|
1176
|
An Act relative to promoting comprehensive transparency in the pharmaceutical industry
|
Support
|
$0.00
|
N/A
|
House Bill
|
984
|
An Act relative to access to care for serious mental illness
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
2520
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
2499
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
631
|
An Act relative to access to care for serious mental illness
|
Support
|
$0.00
|
N/A
|
House Bill
|
4910
|
An Act promoting access and affordability of prescription drugs
|
Support
|
$0.00
|
N/A
|
Executive
|
Lieutenant Governors Office
|
Discussed pro-patient policies including Pharmacy Benefit Managers reform, share the savings, and copay accumulator ban
|
Support
|
$0.00
|
N/A
|
| | |
Total amount
|
$0.00
| |